key: cord-0758856-ay9l3lku
authors: Yang, Chenxi; Song, Chenglin; Liu, Yitong; Qu, Jiao; Li, Haibo; Xiao, Wei; Kong, Lingdong; Ge, Huiming; Sun, Yang; Lv, Wen
title: Re-Du-Ning injection ameliorates LPS-induced lung injury through inhibiting neutrophil extracellular traps formation
date: 2021-06-19
journal: Phytomedicine
DOI: 10.1016/j.phymed.2021.153635
sha: 3c7032e5aeab10cac042991ff7b90e19b3fbe80d
doc_id: 758856
cord_uid: ay9l3lku

BACKGROUND: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening diseases and could occur in severe COVID-19 patients. Re-Du-Ning injection (RDN) is a tradition Chinese medicine preparation which has been clinically used for treatment of respiratory diseases including COVID-19. PURPOSE: To elucidate the potential mechanisms of RDN for the treatment of ALI. METHODS: Female C57BL/6J mice were used to establish ALI model by intraperitoneal injection 10 mg/kg LPS, and RDN injection was intraperitoneally administered with the dose of 5 and 10 mL/kg. The cytokines were measured by ELISA and qPCR. The data related to NETs were analyzed by ELISA, immunofluorescence, Western blotting and network pharmacological approach. RESULTS: RDN robustly alleviated LPS-induced ALI. Meanwhile, RDN downregulated the expression of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α. Specifically, RDN treatment inhibited the formation of neutrophil extracellular traps (NETs) and remarkably suppressed the protein of PAD4. The active compound from RDN decreased the phosphorylation of ERK1/2. CONCLUSION: These findings demonstrate that RDN ameliorates LPS-induced ALI through suppressing MAPK pathway to inhibit the formation of NETs.

The mobile phase consisted of methanol (A) and water containing 0.1% formic acid 158 (B). A gradient program was used as follows: 0~10 min，15~25% A；10~60 min， 159 25~50% A； 60~65 min， 50~100% A； 65~70 min， 100~100% A； 70~75 min， 100~15% 160 A. The flow rate was 0.8 mL/min. The column temperature was 30 ℃. The DAD 161 detector scanned from 190 to 400nm, and the samples were detected at 220 nm. The mouse lungs were fixed in 10% formalin and removed for paraffin, and then 178 sections were stained with hematoxylin and eosin. The pathologic scores were based 179 on published criteria (Szapiel et al.,1979) Hercules, CA). The amplification program was 1 cycle of 95 °C for 2. 

To assess the in vivo impact of RDN injection on lung, we used LPS-induced acute 244 lung injury model ( Fig. 2A) . Compared with LPS group, RDN significantly improved 245 survival of mice (Fig. 2B) . The lung histological studies also showed that 246 administration of RDN reduced peribronchial and perivascular leukocyte infiltration 247 

To explore the impacts of inflammatory cytokines, we detected typical cytokines in 259 the plasma and BALF, such as IL-1β, IL-6, TNF-α, IL-17A and GM-CSF. The LPS 260 group showed significantly high levels of inflammatory cytokines in the serum and 261 BALF. However, administration of RDN effectively reduced the levels of cytokines 262 contrasted with the LPS group (Fig. 4A, B) . The mRNA expressions of cytokines, 263 such as IL-1β, IL-6 and TNF-α, were remarkably elevated after LPS challenge. RDN 264 decreased these cytokines in a dose-dependent manner (Fig. 4C) . of NE and MPO in the serum, BALF and lung tissue, and also found they were 272 significantly decreased after RDN treatment (Fig. 5B, C) . Next, we performed 273 immunofluorescence staining of lung sections and observed that NETs formation in 274 RDN group was reduced compared with the LPS group (Fig. 5D ). Western blot 275 analysis revealed that the protein levels of PAD4 decreased after RDN administration 276 compared to LPS injection in mice (Fig. 5E) . 277

278

In order to obtain the targets of RDN, we collected from TCMSP and DrugBank 280 database. A total of 249 RDN-related targets were obtained. The targets entries related 281 to acute lung injury were collected from the GeneCards database and 1608 targets 282 were obtained. As a result, there were 171 targets in overlapping part between the 283 targets of RDN and acute lung injury (Fig. 6A) . Some typical targets, such as PADI4 284 etc, were shown in Fig. 6B . Next, we analyzed 171 mutual targets via KEGG pathway 285 enrichment (Fig. 6C) Secoxyloganin from Lonicera japonica Thunb. and scopoletin from Artemisia 293 annua L. obviously inhibited the expression of MPO in a dose-dependent manner (Fig.  294 7A, B). As shown in Fig. 6C , RDN may inhibited the formation of NETs through 295 MAPK pathway. We found that secoxyloganin suppressed the phosphorylation of 296 ERK1/2 (Fig. 7C, D) . Graphical abstract 551

Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms

The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury 396 in mice

Neutrophil 399 extracellular traps release induced by Leishmania: role of PI3Kgamma, ERK, PI3Ksigma, PKC, 400 and

A2B adenosine receptor signaling 402 attenuates acute lung injury by enhancing alveolar fluid clearance in mice

UPLC 405

MS-based metabolic profiling of urine reveals the novel antipyretic mechanisms of 406 qingkailing injection in a rat model of yeast-induced pyrexia

Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic 410 mechanism of Reduning injection in a rat model

Influences of Re Du Ning Injection, a traditional Chinese medicine injection, on the 413 CYP450 activities in rats using a cocktail method

Maresin 1 mitigates LPS-induced acute lung injury in mice

NETs in pneumonia: is just enough the right amount?

Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation

Comparative efficacy of Chinese 422 herbal injections for the treatment of community-acquired pneumonia: A Bayesian network 423 meta-analysis of randomized controlled trials

Dissecting the novel 426 mechanism of Reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on 427 network pharmacology and experimental verification

Reduning injection 429 ameliorates paraquat-induced acute lung injury by regulating AMPK/ MAPK/NF-kappaB 430 signaling

Posttreatment with 432 aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in 433 mice: the role of heme oxygenase-1

Maladaptive role of 438 neutrophil extracellular traps in pathogen-induced lung injury

PAD4 is essential for 440 antibacterial innate immunity mediated by neutrophil extracellular traps

Neutrophil extracellular traps are indirectly triggered by 444 lipopolysaccharide and contribute to acute lung injury

IRF-1 Intervention in the Classical ROS-Dependent Release of NETs during LPS-Induced Acute 447 Lung Injury in Mice

The acute respiratory distress syndrome

Acute respiratory distress syndrome

Animal models of acute lung injury

Insight into the 456 molecular mechanism of a herbal injection by integrating network pharmacology and in vitro

Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with 460 ventilator-associated pneumonia

Neutrophil extracellular traps in immunity and disease

Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by 465 down-regulating MAPK and NF-κB pathways

Neutrophil extracellular traps directly induce epithelial and endothelial 468 cell death: a predominant role of histones

PAD4-mediated neutrophil extracellular trap 470 formation is not required for immunity against influenza infection

Neutrophil extracellular traps: the biology of 472 chromatin externalization

Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse

Effects of Reduning Injection on Lipopolysaccharide-Induced Acute Lung 478 Injury of Rats

Human PAD4 regulates histone arginine methylation levels via 482 demethylimination

Protostemonine effectively attenuates 484 lipopolysaccharide-induced acute lung injury in mice

SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 493 pathology